• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Capmatinib-[13C,d3]

General Information
Catalog: BLP-014042
Molecular Formula: C22[13C]H14D3FN6O
Molecular Weight: 416.4
Chemical Structure
Capmatinib-[13C,d3]
Description Capmatinib-[13C,d3] is a labelled capmatinib. Capmatinib is an orally bioavailable inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. It selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways.
Synonyms [13C,d3]-INCB28060; [13C,d3]-UNII-TY34L4F9OZ; 2-fluoro-N-(methyl-13C-d3)-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide; 2-fluoro-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-N-(trideuterio(113C)methyl)benzamide
Related CAS 1029712-80-8 (unlabelled)
Purity ≥99% atom 13C; ≥98% atom D

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket